Vaccine Specialist AFFiRiS AG successfully completes Financing Round
• € 10m additional capital raised
• Supervisory Board appoints Oliver Siegel as Chief Executive Officer
• Prof. Dr. Christoph Huber elected to Supervisory Board
AFFiRiS AG has successfully completed its capital increase and raises an additional € 10m
↧